Alpha-1 antitrypsin deficiency: outstanding questions and future directions

Alpha-1 antitrypsin deficiency: outstanding questions and future directions

Abstract Background Alpha-1 antitrypsin deficiency (AATD) is a rare hereditary condition that leads to decreased circulating alpha-1 antitrypsin (AAT) levels, significantly increasing the risk of serious lung and/or liver disease in children and adults, in which some aspects remain unresolved. Metho...

Full description

Bibliographic Details
Main Authors:	María Torres-Durán, José Luis Lopez-Campos, Miriam Barrecheguren, Marc Miravitlles, Beatriz Martinez-Delgado, Silvia Castillo, Amparo Escribano, Adolfo Baloira, María Mercedes Navarro-Garcia, Daniel Pellicer, Lucía Bañuls, María Magallón, Francisco Casas, Francisco Dasí
Format:	Article
Language:	English
Published:	BMC 2018-07-01
Series:	Orphanet Journal of Rare Diseases
Subjects:	Rare respiratory diseases Alpha-1 antitrypsin Alpha-1 antitrypsin deficiency SERPINA1 Augmentation therapy COPD
Online Access:	http://link.springer.com/article/10.1186/s13023-018-0856-9

Similar Items

Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma
by: I. Blanco, et al.
Published: (2016-01-01)

Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
by: Sabri Denden, et al.
Published: (2010-01-01)

Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center
by: Friedrich Kueppers
Published: (2021-01-01)

Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
by: Friedrich Kueppers, et al.
Published: (2019-07-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

Description of 22 new alpha-1 antitrypsin genetic variants
by: Céline Renoux, et al.
Published: (2018-09-01)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
by: Veith M, et al.
Published: (2020-11-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
by: Belchamber KBR, et al.
Published: (2020-12-01)

Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
by: Magda Oliveira Seixas Carvalho, et al.
Published: (2017-11-01)

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
by: Carleo A, et al.
Published: (2017-03-01)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018-03-01)

Prevalence of the serpin peptidase inhibitor (alpha-1-antitrypsin) PI*S and PI*Z alleles in Brazilian children with liver disease
by: Guilherme Baldo, et al.
Published: (2008-01-01)

The Course of AαVal541 as a Proteinase 3 Specific Neo-Epitope after Alpha-1-Antitrypsin Augmentation in Severe Deficient Patients
by: Iris G. M. Schouten, et al.
Published: (2021-07-01)

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
by: Rahaghi FF, et al.
Published: (2020-12-01)

PI S and PI Z Alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data
by: F.J. de Serres, et al.
Published: (2016-02-01)

Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America
by: F.J. de Serres, et al.
Published: (2016-01-01)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
by: Franck F. Rahaghi, et al.
Published: (2017-05-01)

Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
by: I. Suárez-Lorenzo, et al.
Published: (2018-11-01)

Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
by: José Luis López-Campos, et al.
Published: (2020-08-01)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
by: Rodrigo Russo, et al.

Polymorphism of alpha-1-antitrypsin in hematological malignancies
by: Aleksandra Topic, et al.
Published: (2009-01-01)

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)
by: Esquinas C, et al.
Published: (2018-03-01)

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.

α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke
by: Berman R, et al.
Published: (2016-06-01)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
by: Francesco Callea, et al.
Published: (2018-05-01)

Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
by: Stockley RA, et al.
Published: (2016-08-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Utility of Transient Elastography for the Screening of Liver Disease in Patients with Alpha1-Antitrypsin Deficiency
by: Mònica Pons, et al.
Published: (2021-04-01)

Clinical Practice Guideline Implementation for Alpha-1 Antitrypsin Deficiency Testing: Evaluation of an Innovative Method
by: Steffen, Priscilla
Published: (2010)

Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein
by: Urszula Lechowicz, et al.
Published: (2020-12-01)

Systemic inflammation in COPD in relation to smoking status
by: Serapinas Danielius, et al.
Published: (2011-08-01)

Patterns and characterization of COPD exacerbations using real-time data collection
by: Ejiofor SI, et al.
Published: (2017-01-01)

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement
by: Andrea Gramegna, et al.
Published: (2018-10-01)

Effect of alpha-1antitrypsin,adiponectine,leptein in obesity
by: Halla G. Mahmood
Published: (2014-01-01)

Identification of bioactive molecules for the treatment of alpha₁-antitrypsin deficiency
by: Ekeowa, Ugochukwu Ifedi
Published: (2012)

Whole exome sequencing in a juvenile idiopathic arthritis large family with SERPINA1 gene mutations
by: Popescu, C.
Published: (2022)

Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
by: Barrecheguren M, et al.
Published: (2016-05-01)

Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches
by: Simona Viglio, et al.
Published: (2021-01-01)

Improving adherence to alpha-1 antitrypsin deficiency screening guidelines using the pulmonary function laboratory
by: Luna Diaz LV, et al.
Published: (2017-07-01)